226 Users Online
Veterinary Molecular Diagnostics Market by Product (PCR Kits, INAAT Kits, Microarray Kits, DNA Sequencing Kits)
The Global revenue from the Veterinary Molecular Diagnostics Market was approximately US$ 183.4 Million in 2022, with the global market expected to grow at a CAGR of 8.2% to reach a valuation of approximately US$ 437.7 Million by the end of 2033.
Market Size (2023)
US$ 198.4 Million
Projected Market Value (2033)
US$ 437.7 Million
Global Market Growth Rate (2023 to 2033)
Market Share of Top 5 Countries (2022)
As assessed by Persistence Market Research, PCR kits held a market share of around 50.8% in the global market, in 2022. Overall, veterinary molecular diagnostics market sales account for around 5.2% of revenue share in the global veterinary diagnostics market, which was valued at around US$ 3.5 Billion in 2022.
The Global Veterinary Molecular Diagnostics Market recorded a historic CAGR of 7.0% in the last 7 years from 2015 to 2022.
Veterinary Diagnostic Market is an emerging industry that incorporates technologically upgraded diagnostic products and solutions to screen variant diseases in pet and farm animals. Increasing consumption of milk products and meat, introduction of new diseases in animals and transmission of these infectious diseases (e.g. Anthrax, Plague, etc.) from animals to human beings are some of the major factors propelling animal diagnostics market globally.
Increased in farm animals or pet adoption in developed and emerging countries, as well as an increase in the availability of medical information via the internet, are factors driving the global veterinary diagnosis market. In this regard, the American Pet Products Association estimates that about 63.4 million households in the U.S. will own a dog by 2020. The availability of readily available information makes pet owners extremely perceptive, raising the demand for quality veterinary care.
The demand for pet insurance in emerging countries is an upcoming trend. According North American Pet Health Insurance Association (NAPHIA), the total number of pets insured reached 2.43 Million in 2018, which is 17% over from 2017. Introduction of these third-party payers is expected to boost the turnover of the veterinary molecular diagnostics segment globally, and lead to build-up of new sales channel for molecular diagnostic kits and reagents and other pet diagnostic services.
“Greater consumer preference owed to accuracy and precision of molecular tests”
The ability to offer improved testing efficiency and reliability of diagnostic test results obtained through United States FDA-licensed diagnostic solutions coupled with high specificity of DNA/RNA-based tests have made molecular diagnostic kits a preference for veterinary physicians, as molecular diagnostics for animals is 99.0% reliable, reproducibility, sensitivity, fast pathogen detection (time around 1.5 hours only). The testing process is a simple automated workflow with less sample handling, and hence avoid cross-contamination. For instance, FDA-approved BIOFIRE Blood Culture Identification 2 (BCID2) Panel in April 2019. These factors are expected to boost the revenue generation.
Zoonotic diseases are extremely common and contagious in developed countries like the United States, China, and globally as well. According to animal research study done in 2020 by Word Health Organization, zoonotic origin about 60% and 70% wildlife sources contributing the infectious diseases in humans.
Financial grants for innovation in veterinary diagnostics is also boosting the global market. In 2017, Thermo Fisher Scientific Inc. sponsored the American Association of Veterinary Laboratory Diagnosticians (AAVLD) Innovation in Veterinary Diagnostic Medicine Grant Program to focus on empowering the veterinary diagnostic medicine advancements in the near future.
“Gaps in epidemiological knowledge of certain virulent veterinary diseases, and inadequate veterinary services”
A significant knowledge gap in the epidemiology of endemic veterinary diseases is the key barrier to global market growth. For instance, the substantial economic loss caused by the lack of epidemiological understanding of Newcastle Disease outbreak in chicken and other species. Accelerated mutation caused significant knowledge gaps in the study of various vNDV genotypes.
Historically, Veterinary Surgeons have been in short supply in the United Kingdom As a result, these roles have long been on the ‘shortage occupation’ list. The Britain’s exit from European Union in March 2019 has further reduced the number of veterinary practitioners practicing in United Kingdom There is also a lack of training, basic equipment, and participation in pet animal services and framing public health policy.
Many vet owners have pet insurance that typically covers maximum cost associated with molecular diagnosis of disease, but for the rest of owners who are not covered under pet insurance registers high out of pocket expenditures. However, the molecular diagnosis technique is cost prohibitive for a large number of pet owners, as they do not have pet insurance scheme. The cost of a RT-PCR kit is high for low household income families, thus pet owners prefer other diagnostic methods that incur low costs.
Why is the United States Market Booming?
“High pet adoption rate, high meat consumption, and advanced diagnostic kits”
The United States Market held around 34.6% market share of the global market in 2022.
The American Society for the Prevention of Cruelty is also sheltering the pet animals at about 6.3 Million every year. Among them, 3.2 Million are cats and 3.1 Million are dogs. United States people also adopting these sheltered pets at about 2.1 Million cats and 2 Million dogs every year; hence increasing pet healthcare spending.
The United States consumes a lot of meat, milk, and eggs in addition to adopting pets and farm animals; as a result, animals need to be diagnosed before being consumed. For instance, the World Animal Foundation estimates that pneumonia infects 80% of the hog meat consumed worldwide. According CDC, Salmonella zoonotic outbreak was common in the United States in 2021. Chicken and beef were infected by Salmonella bacteria. During the forecast period, the continued advancement of diagnostic techniques, particularly RT-PCR, will fuel the growth of the veterinary molecular diagnostics market.
Will the Germany Be a Lucrative Market for Veterinary Diagnostics?
“Animals as the main source of food-borne pathogens driving market”
Germany market held around 9.7% market share of the global market in 2022 and it is expected to expand over the forecast period, due to high virulence factors present in meat because of bacteria carrying animals.
Germany has a high rate of meat consumption. Animals used in food production are also mainly carrier of pathogens, such as non-Typhi serotypes of Salmonella enterics, Shiga toxin-producing strains of Escherichia coli (STEC), and Campylobacter species.
As per “Norma Heredia, Santos García, Animals as sources of food-borne pathogens: A review, Animal Nutrition, Volume 4, Issue 3, 2018”, in the pathogen strain isolation study, the virulence factors were found in cattle, sheep, goats, pigs, cats, and dogs, except in chickens. These animals were infected before slaughtering STEC has ability to produce diseases related to gastrointestinal, urinary, and central nervous system.
How is China Emerging as a Prominent Market?
“Emerging infectious diseases from Chinese live and wet markets”
China holds a market share of about 1.8% of the global market in 2022.
Pet adoption in China is low, but it has been increasing since COVID-19, owing to the fact that cats and dogs are the most popular human companions among all domesticated animals, and their bonds with humans provide mutual psychosocial health benefits.
According to published article on live and wet markets with study of food access and risk of disease emergence in the Trends in Microbiology journal 2021, explaining about emerging zoonotic diseases are responsible for increase in human health concerns and its impact on society and thus on world. As per study, the live and wet markets are supplying fresh products to millions of customers and also becoming the cause for infectious diseases transfer from animals to humans. In 2002-2003, a SARS outbreak in southern China was caused by a coronavirus later identified as SARS-CoV. A new pandemic, coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has recently been linked to a LWM in Wuhan, China's Hubei province.
Which Product is Driving Demand within the Global Market?
“Emerging infectious diseases and reliability of results by the PCR kits”
PCR kits held about 50.8% share of the global market in 2022 because of precise and reliable results in less time.
The recent example of COVID-19 infectious disease spread globally through the Chinese wet market. Polymerase Chain Reaction (PCR) can be used to rapidly detect other bacteria, viruses that grow slowly in cell culture media. PCR is faster and precise than cultures.
Animal disease diagnostics is a critical step between disease cause and cure. When deciding on a treatment plan for other animals, the cause of death is critical information to have. Hence, the market shares of PCR kits is high.
Which Species is Largely in Focus within the Global Market?
“Livestock animals provide food supply and hence need of animal disease management and prevention”
Livestock animals held around 71.0% share of the global market in 2022.
Globally, people are consuming foods of animal sources like fish, meat, egg, chicken, and dairy products as a nutritious diet.
Diagnostics for animal diseases have been linked to disease cause and cure. It is also useful for disease management and prevention. As the corona pandemic demonstrated, even a minor outbreak of disease can endanger the entire animal community and easily spread to humans. As a result, livestock animal diagnosis is propelling the global market forward.
Which Disease Propels the Global Market?
“Newcastle disease can be present in very acute form and highly deadly for birds and is highly contagious”
Newcastle disease held around 31.3% share in the global market in 2022.
Newcastle disease is believed to have been reported for the first time in 1926 and then last seen in 2006 in England. Hence, people are aware of prevention and treatment of this disease for their livestock and birds, and are undertaking diagnostic testing from time to time. Livestock bird including geese, turkeys, ducks, and partridges other wild and captive birds like ostriches, etc. According to National Cancer Institute, Newcastle virus (NDV) causes dreadful infection in various types of birds. In humans, NDV causes mild conjunctivitis, flu-like symptoms, or laryngitis.
The NDV can be easily spread from birds to humans through birds dropping and secretions by possible contact through vehicles, clothes, feed, and water.
Which End User is helping to expand the Global Market?
“Need of routine check-ups for farm animals and pets to avoid infectious diseases”
By end user, veterinary hospitals held a global market share of around 49.7% in 2022.
A veterinary hospital provides diagnosis, medication, and care for animals. A veterinary hospital is concerned with the treatment of wounds, disorders, and illnesses, as well as animal breeding, husbandry, rearing, and husbandry, product development, and nutrition research.
Veterinary hospital market shares are increasing during the forecast period due to an increase in pet adoption, which necessitates regular check-ups, grooming, and disease prevention measures such as early disease detection before it worsens. Emerging countries also having farm animals is further contributing in the global market growth.
To compete in the market, the key players are employing a variety of market strategies. Such strategies include a partnership agreement between the manufacturer and the supplier, as well as product marketing to capture the maximum market share. Another strategy could be opportunistic manufacturing in terms of immediate demand, such as the spread of contagious diseases like strep throats, colds, and flu.
A few examples of strategies acquired by the key players:
Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the veterinary molecular diagnostics market, which are available in the full report.
2023 to 2033
Historical Data Available for
2015 to 2022
US$ Million for Value
Key Countries Covered
Key Market Segments Covered
Key Companies Covered
Customization & Pricing
Available upon Request
The global market is valued at around US$ 183.4 Million in 2022.
Sales of the market are set to witness growth at a CAGR of 8.0% and be valued at around US$ 437.7 Million by 2033.
Demand for the global market increased at a 7.0% CAGR from 2015 to 2022.
The U.S., Germany, France, Spain, and Australia & New Zealand account for most demand within the market, and were holding around 62.9% market share in 2022.
bioMérieux SA, IDEXX Laboratories, Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Neogen Corporation, ID. Vet, INDICAL BIOSCIENCE GmbH, and Veterinary Molecular Diagnostics, Inc. are the key players of the global market.
Livestock animals held market share round 71.0% in 2022 global market.
The U.S. accounts for around 34.6% share of the global market in 2022.
France accounts for around 4.5% share of the global market in 2022.
The Spanish market held a share of about 6.1% in the global market in 2022.
The veterinary molecular diagnostics industry in China is holding 1.8% market share in 2022.